Phathom Pharmaceuticals Inc. (PHAT)
NASDAQ · Healthcare
Phathom Pharmaceuticals Inc. Operating Income 2022–2025
Phathom Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2022 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Phathom Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -15.5 M, a 80.37% decrease year-over-year.
- Phathom Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -169.5 M, a 33.18% decrease year-over-year.
- Phathom Pharmaceuticals Inc. annual operating income for 2025 was -160.0 M, a 42.34% decrease from 2024.
- Phathom Pharmaceuticals Inc. annual operating income for 2024 was -277.5 M, a 65.84% increase from 2023.
- Phathom Pharmaceuticals Inc. annual operating income for 2023 was -167.3 M, a 2.97% decrease from 2022.
- Phathom Pharmaceuticals Inc. annual operating income for 2022 was -172.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Phathom Pharmaceuticals Inc. Operating Income — FAQ
Phathom Pharmaceuticals Inc. (PHAT) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Phathom Pharmaceuticals Inc.'s operating income?
Phathom Pharmaceuticals Inc. (PHAT) reported operating income of -$160M for fiscal 2025.
Where can I see PHAT's operating income history?
The chart and table above show Phathom Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.